EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial
Recruiting · NCT06767332 · Interventional (participants receive a specific treatment) · Lead sponsor: Leiden University Medical Center
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
High fear of cancer recurrence (FCR) impacts patient's quality of life (QoL) and is prevalent among patients with familial melanoma. The main objective is to investigate whether EMDR is effective in treating high FCR in patients with familial melanoma. The study design is a non-blinded, randomized waiting-list controlled trial. Patients aged 18 years or older with familial melanoma can be included. Patients with high FCR will receive a maximum of 4, 90 minutes, EMDR-sessions. The main study parameter is the decrease and level of FCR measured with the Cancer Worry Scale (CWS). The secondary study parameter is quality of life, measured with the EORTC.
Who can take part
Inclusion criteria
- a score of 16 or higher on the FCRI-NL-SF
- 18 years or older
- diagnosed with familial melanoma
Exclusion criteria
- insufficient knowledge of the Dutch language.
- acute psychiatric disease (psychosis, suicidal ideation)
- variable dosis of anxiolytics
Where it is running
2 locations listed.
- Leiden University Medical Center - Leiden, South Holland, Netherlands
- Leiden University Medical Centre - Leiden, South Holland, Netherlands